Options: Hide MedDRA Preferred Terms
| MedDRA Preferred Term | Side effect | Data for drug | Placebo | Labels | |
|---|---|---|---|---|---|
| 1 | 2 | ||||
| Anaphylactic shock | Anaphylactic shock | x | x | ||
| Angioedema | Angioedema | x | |||
| Decreased appetite | Anorexia | x | x | ||
| Dizziness | Dizziness | x | x | ||
| Dyspepsia | Dyspepsia | x | x | ||
| Heartburn | x | x | |||
| Dermatitis | Rash | x | x | ||
| Rash | Rash | x | x | ||
| Headache | Headache | x | x | ||
| Hypersensitivity | Hypersensitivity | x | x | ||
| Immune system disorder | Immune system disorder | x | x | ||
| Urticaria | Urticaria | x | x | ||
| Malaise | Malaise | x | x | ||
| Discomfort | Malaise | x | x | ||
| Feeling abnormal | Malaise | x | x | ||
| Ill-defined disorder | Malaise | x | x | ||
| Face oedema | Face oedema | x | x | ||
| Insomnia | Insomnia | x | x | ||
Information about indications was extracted from the indications and usage sections of the labels.
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |